FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40202411000001108: Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2504091000001116 Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2504101000001110 Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Is a Cenobamate 100mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Has AMP Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) true Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ontozry 100mg tablets (Angelini Pharma UK-I Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Cenobamate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start